ICL Group에 대한 매도 수량은 투자자에게 ICL Group의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

ICL Group (NYSE:ICL) 주식, 공매도 수량 보고

ICL Group

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North and South America, and the Rest of the world.

Equities

Markets

ETFs

ADRT

ARGT

BSAC

DFEN

DXYZ

GOLD

JCPB

NUSI

UPRO

XPER

뉴욕 증권 거래소(NYSE)의 여러 주식들은 기술적 문제로 인해 월요일 동부 표준시 오전 9시 40분 이후 갑자기 거래가 중단되었다. 이번 예상치 못한 거래 중단은 일반적으로 단일 주식의 과도한 변동성을 억제하는 데 사용되는 &#34;상향 한도(Limit Up)/하향 한도(Limit Down)&#34; 코드로 분류된 기술적 문제로 인해 촉발되었다.

버크셔 해서웨이, 치폴레 등 뉴욕 증권 거래소 기술적 문제로 일시 거래 중단 발생

ICL Group Ltd

INTERCLOUD SYSTEMS by InterCloud Systems, Inc.

InterCloud Systems Inc

iClick Interactive Asia Group Limited - American Depositary Shares

iClick Interactive Asia Group Ltd

iShares Global Clean Energy ETF

Invesco Actively Managed Exchange-Traded Fund Trus Invesco AAA CLO Floating Rate Note ETF

Icon PLC

GreenFirst Forest Products Inc

GREENFIRST FOREST PRD NEW by GreenFirst Forest Products Inc. NEW

WIIM

ICL Group shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY24 specialties-driven EBITDA guidance.

<h3>Companies Reporting Before The Bell</h3>
• Global Ship Lease (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSL#NYSE">GSL</a>) is projected to report quarterly earnings at $2.41 per share on revenue of $174.31 million. 
• Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $246.09 million. 
• Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $4.46 billion. 
• ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $2.03 billion. 
• Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $110.77 million. 
• Strawberry Fields REIT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STRW#AMEX">STRW</a>) is estimated to report earnings for its third quarter. 
• Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) is projected to report quarterly earnings at $0.38 per share on revenue of $140.07 million. 
• Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.28 per share on revenue of $2.36 million. 
• GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) is estimated to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) is expected to report quarterly loss at $0.01 per share on revenue of $691.80 million. 
• Ispire Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPR#NASDAQ">ISPR</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $52.81 million. 
• Talos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TALO#NYSE">TALO</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $500.03 million. 
• Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) is estimated to report earnings for its third quarter. 
• Mineralys Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) is expected to report earnings for its third quarter. 
• Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) is likely to report quarterly earnings at $1.71 per share on revenue of $8.09 billion. 
• Gatos Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATO#NYSE">GATO</a>) is projected to report earnings for its third quarter. 
• Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is likely to report earnings for its third quarter. 
• Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $283.55 million. 
• Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is likely to report earnings for its third quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $30.69 million. 
• Bioceres Crop Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $120.80 million. 
• RMR Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMR#NASDAQ">RMR</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $220.35 million. 
• Assertio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $28.87 million. 
• Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) is projected to report quarterly loss at $0.28 per share on revenue of $1.04 million. 
• Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $57.50 million. 
• Aterian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATER#NASDAQ">ATER</a>) is expected to report quarterly loss at $0.55 per share on revenue of $26.01 million. 
• QuickLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUIK#NASDAQ">QUIK</a>) is likely to report quarterly loss at $0.05 per share on revenue of $4.20 million. 
• VAALCO Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGY#NYSE">EGY</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $145.89 million. 
• Assured Guaranty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGO#NYSE">AGO</a>) is projected to report quarterly earnings at $1.36 per share on revenue of $201.37 million. 
• Stereotaxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STXS#AMEX">STXS</a>) is likely to report quarterly loss at $0.05 per share on revenue of $7.10 million. 
• NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $3.00 million. 
• Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) is expected to report quarterly loss at $0.17 per share on revenue of $18.68 million. 
• James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $146.56 million. 
• Crescent Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCAP#NASDAQ">CCAP</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $48.69 million. 
• IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is estimated to report quarterly loss at $0.28 per share on revenue of $923.69 million. 
• Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $298.54 million. 
• Intevac (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVAC#NASDAQ">IVAC</a>) is expected to report quarterly loss at $0.15 per share on revenue of $11.50 million. 
• Nevro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVRO#NYSE">NVRO</a>) is likely to report quarterly loss at $0.81 per share on revenue of $93.07 million. 
• Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $248.65 million. 
• DoubleDown Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDI#NASDAQ">DDI</a>) is estimated to report quarterly earnings at $0.55 per share on revenue of $85.43 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

ANGI

ARMK

AROC

ASRT

ATER

BAER

BIOX

CCAP

GATO

GRAB

ISPR

IVAC

JRVR

LAZR

LINC

MLYS

MNDY

NPWR

NUWE

NVRO

QUIK

SPNS

STRW

STXS

TALO

TISI

XAIR

YALA

ZETA

Earnings Scheduled For November 11, 2024

The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.95 billion to $1.05 billion, an increase from previous guidance of $0.8 billion to $1.0 billion. The company intends to limit its total 2024 annual potash sales volumes to 4.6 million metric tons, already committed, which is in-line with 2023 sales volumes and in expectation of improved conditions in 2025.

News

Guidance

ICL Raised Its FY24 Guidance For Specialties-Driven EBITDA To $0.95B-$1.05B From $0.8B-$1B

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.753 billion which missed the analyst consensus estimate of $1.788 billion by 1.98 percent. This is a 5.85 percent decrease over sales of $1.862 billion the same period last year.

Earnings Beats

Earnings Misses

ICL Group Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $1.753B Miss $1.788B Estimate

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) is preparing to release its quarterly earnings on Monday, 2024-11-11. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect ICL Group to report an earnings per share (EPS) of $0.09.
Anticipation surrounds ICL Group's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.95% increase in the share price the next day.
Here's a look at ICL Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.08</td>
<td>0.09</td>
<td>0.08</td>
<td>0.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.10</td>
<td>0.09</td>
<td>0.10</td>
<td>0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>4.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731074516_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of ICL Group were trading at $4.23 as of November 07. Over the last 52-week period, shares are down 10.0%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/ICL/earnings">To track all earnings releases for ICL Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ICL Group's Earnings: A Preview

Company signs MOU to supply key component for production of LiPF6 battery materials
ICL (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a memorandum of understanding (MOU) with Orbia Advance Corp., S.A.B. de C.V. (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ORBIA#BMV">ORBIA</a>) Fluor &amp; Energy Materials (OF&amp;EM), as both companies continue to expand their presence in the North American battery materials supply chain. The MOU provides a framework for ICL's Industrial Products division to supply phosphorus trichloride (PCl3) to OF&amp;EM for its use in the production of LiPF6 – a critical raw material for lithium-ion batteries – at its planned St. Gabriel, La., manufacturing plant. ICL produces PCl3 at its plants in Gallipolis Ferry, W.Va., and in Bitterfeld, Germany, and is considered a leading global supplier of this high-quality material necessary for this essential battery component.
This partnership allows ICL and OF&amp;EM to work together to advance electrification for both transportation and stationary applications and to bring the production of this critical component to North America. It will also enable them to optimize the performance, efficiency and safety of batteries used in consumer electronics, energy storage and other applications.

BMV:ORBIA

ICL Announced It Has Signed A MoU With Orbia Advance Corp., S.A.B. de C.V. Fluor & Energy Materials, As Both Companies Continue To Expand Their Presence In The North American Battery Materials Supply Chain

Biotech

General

SeaStar Medical Reports Strong Enrollment Progress In Pivotal Adult AKI Trial With 46 Total Subjects Enrolled; Trial Evaluates Safety And Efficacy Of Selective Cytopheretic Device For Acute Kidney Injury Patients In ICU

ICL Expands In China With New Food Specialty Plant In Zhangjiagang Free Trade Zone, Focuses On Innovative Solutions For Meat, Poultry, And Seafood Segments

Growing Solutions signs agreement with AMP Holdings Group for specialty water soluble fertilizers
ICL (NYSE:<a href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has signed a five-year agreement with AMP Holdings Group Co. Ltd., one of China's top agricultural distribution companies. The agreement, valued at approximately $170 million, will run until 2028 and advances ICL's stated goal to expand its Growing Solutions product offerings and to position the business for further growth in major end-markets.
The agreement is for specialty water soluble fertilizers, which are used in drip irrigation and designed for cash-crops, such as apples, watermelons, vegetables, strawberries, ginger and grapes. It includes a minimum purchase commitment, with certain exclusivity conditions based on brand and region.

Contracts

ICL Signed A 5-Year Agreement With AMP Holdings Group Co, Continues Global Specialty Fertilizers Expansion With ~$170M Distribution Agreement In China

ICL Group Ltd&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/icl#NYSE">ICL</a>) recorded profits of $115 million or 9 cents per share in second-quarter 2024, down from $163 million or 13 cents in the year-ago quarter.
Barring one-time items, adjusted earnings per share were 10 cents. The bottom line beat the Zacks Consensus Estimate of 9 cents.
Sales fell around 6% yearly to $1,752 million in the quarter. The figure beat the Zacks Consensus Estimate of $1,733.2 million.
<div class="chart_embed">
<h3>ICL Group Ltd. Price, Consensus and EPS Surprise</h3>
<img alt="ICL Group Ltd. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/bc/1723803929.png" style="height:265px; width:570px" title="" />
ICL Group Ltd. price-consensus-eps-surprise-chart | ICL Group Ltd. Quote
</div>
<h3>Segment Highlights</h3>
Sales in the Industrial Products segment rose 5% year over year to $315 million in the quarter. EBITDA remained flat year over year at $74 million. This marks the third consecutive quarter of sequential EBITDA improvement, driven by ongoing cost-saving efforts and strengthening customer relationships.
Sales in the Potash segment dropped 27.5% year over year to $422 million in the said quarter. EBITDA also fell 44% year over year to $118 million.
Sales in the Phosphate Solutions segment inched up 1% year over year, reaching $572 million in the quarter. EBITDA rose 13% year over year to $146 million. This marks the second consecutive quarter of sequential sales improvement, with EBITDA up 11% sequentially. Pricing remained stable during the quarter, though evolving supply dynamics are anticipated to impact future performance.
Sales in the Growing Solutions segment rose 3% year over year to $494 million in the quarter. EBITDA nearly doubled from $22 million registered in the same period last year to $45 million.
<h3>Financials</h3>
At the end of the quarter, ICL had cash and cash equivalents of $287 million, down around 23% year over year. Long-term debt was $1,850 million, down nearly 13% year over year.
Cash provided by operating activities was $316 million in the reported quarter.
<h3>Guidance</h3>
The company updated its full-year 2024 guidance, now projecting specialties-driven EBITDA of $0.8 billion to $1 billion, compared with the previous guidance of $0.7 billion to $0.9 billion. The expected potash sales volumes remain unchanged in the range of 4.6-4.9 million metric tons.
<h3>Price Performance</h3>
ICL&#39;s shares have lost 31.1% in the past year compared with a 23.9% decline in the&nbsp;industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/18/74444.jpg?v=1004147804" />
Image Source: Zacks Investment Research
<h3>Zacks Rank &amp; Key Picks</h3>
ICL currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Newmont Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nem#NYSE">NEM</a>), Franco-Nevada Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fnv#NYSE">FNV</a>) and Agnico Eagle Mines Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aem#NYSE">AEM</a>). Newmont and Franco-Nevada sport a Zacks Rank #1 (Strong Buy), and Agnico Eagle carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Newmont&#39;s current-year earnings is pegged at $2.82, indicating a rise of 75% from year-ago levels. The consensus estimate for NEM&#39;s earnings has increased 16% in the past 60 days.The stock has gained nearly 28.8% in the past year.
The Zacks Consensus Estimate for FNV&#39;s current-year earnings is pegged at $3.27. The consensus estimate for FNV&#39;s earnings has increased by 3% in the past 60 days. FNV beat the consensus estimate in the last four quarters, with the average earnings surprise being 10.5%.
The Zacks Consensus Estimate for AEM&#39;s current fiscal year earnings is pegged at $3.65, indicating a year-over-year rise of 63.7%. AEM&#39;s earnings beat the Zacks Consensus Estimate in all of the last four quarters, the average earnings surprise being 15.7%. The company&#39;s shares have increased 70% in the past year.
<a href="https://www.zacks.com/stock/news/2323338/icl-group-s-icl-earnings-and-revenues-beat-estimates-in-q2?cid=CS-BENZ-FT-analyst_blog|earnings_article-2323338">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Penny Stocks

Analyst Ratings

Trading Ideas

ICL Group's Earnings and Revenues Beat Estimates in Q2

Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) with a Underweight and lowers the price target from $4.5 to $4.

Price Target

Barclays Maintains Underweight on ICL Group, Lowers Price Target to $4

ICL shares are trading higher after the company raised FY24 guidance.

The company raised its guidance for full year 2024 and now expects specialties-driven EBITDA of between $0.8 billion to $1.0 billion, an increase from previous guidance of $0.7 billion to $0.9 billion, without any change to expected potash sales volumes

ICL Raised Its 2024 Guidance For Specialties-Driven EBITDA To $0.8B-$1B, From $0.7B-$0.9B

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.09 by 11.11 percent. This is a 23.08 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $1.752 billion which missed the analyst consensus estimate of $1.759 billion by 0.40 percent. This is a 4.26 percent decrease over sales of $1.830 billion the same period last year.

ICL Group Q2 2024 Adj. EPS $0.10 Beats $0.09 Estimate, Sales $1.752B Miss $1.759B Estimate

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Monday.
Shares of Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) fell in today&#8217;s pre-market trading after the company was ordered to pay $495 million in damages in its baby formula case.
Abbott shares lost 6.6% to $98.29 in pre-market trading
<ul>
<li>Integra LifeSciences Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) dipped 20.5% to $25.00 in pre-market trading after the company reported second-quarter results and lowered its FY24 outlook.</li>
<li>NewAmsterdam Pharma Company N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMS#NASDAQ">NAMS</a>) fell 13.8% to $16.26 in pre-market trading as the company announced topline data from pivotal Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients wth Heterozygous Familial Hypercholesterolemia.</li>
<li>EZCORP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) shares declined 8.8% to $9.41 in pre-market trading.</li>
<li>GeoPark Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPRK#NYSE">GPRK</a>) shares fell 6.5% to $9.52 in pre-market trading. GeoPark, last week, issued second quarter operational update.</li>
<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) shares dipped 6.5% to $2.03 in pre-market trading. Immutep, last week, announced successful meeting with the FDA on Phase III design in non-small cell lung cancer.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) shares fell 5.4% to $8.75 in pre-market trading.</li>
<li>ICL Group Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) shares fell 4.1% to $4.43 in pre-market trading. ICL will release second quarter results before the opening of the TASE market on Wednesday, Aug. 14.</li>
<li>PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) slipped 3% to $126.84 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39984123/jim-cramer-is-mystified-by-five-below-predicts-crowdstrike-is-going-to-bottom-here">Jim Cramer Is &#8216;Mystified&#8217; By Five Below, Predicts CrowdStrike &#8216;Is Going To Bottom Here&#8217;</a></li>
</ul>

Pre-Market Outlook

Movers

EZPW

GPRK

IART

IMMP

IOVA

NAMS

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

More than one dozen novel microbes identified for row crops&nbsp;suffering from extreme weather conditions
TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viability as bio-stimulants for crops grown under extreme weather conditions, including drought.&nbsp; While this process can normally take several years, the collaboration achieved success within its first 12 months – thanks to Lavie Bio's proprietary Biology Driven Design (BDD) technology platform.

EVGN

ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants

Editor&#8217;s note: This story has been updated with additional details.
Multiple stocks on the New York Stock Exchange experienced sudden trading halts after 9:40 a.m. ET Monday <a href="https://www.benzinga.com/topic/nyse">due to technical issues.</a>
The unexpected pauses in trading were triggered by a technical issue categorized under the &#8220;Limit Up/Limit Down&#8221; code, which is typically used to curb excessive volatility in a single stock.
The NYSE said it is investigating the reported technical issue. &#8220;Additional information will follow as soon as possible,&#8221; NYSE-owner Intercontinental Exchange Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) stated. 
Among the largest companies halted on Monday were Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) at 9:50:52 a.m. ET and Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) at 9:44:58 a.m. ET. 
Chipotle shares experienced a sudden and dramatic decline of 66%, plummeting from $3,097 to $1,047. The stock resumed trading at 10:21 a.m.
At 9:49 a.m., ET shares of Berkshire Hathaway faced an even more severe downturn, nearly being wiped out with a staggering 99.7% collapse from $622,375 to $185.10. As of this update, trading has not yet resumed for the company owned by Warren Buffett.
Monday&#8217;s technical malfunctions on the NYSE occur just one week after U.S. stock exchanges transitioned to a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39039375/t-1-settlement-era-on-trading-begins-what-you-need-to-know">one-day settlement period.</a>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03101722/image-4-1024x500.png" alt="" class="wp-image-368052" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03101722/image-4-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03101722/image-4-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03101722/image-4-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03101722/image-4-1536x750.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03101722/image-4.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03102012/image-5-1024x500.png" alt="" class="wp-image-368067" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03102012/image-5-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03102012/image-5-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03102012/image-5-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03102012/image-5-1536x750.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/03102012/image-5.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">Other Stocks Impacted </h3>
Other stocks affected by the sudden technical glitch on the New York Stock Exchange in Monday trading include:
<ul>
<li>Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>)</li>
<li>Barrick Gold Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>)</li>
<li>Franco-Nevada Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>)</li>
<li>Essex Property Trust, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>)</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>)</li>
<li>Destiny Tech100 Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NYSE">DXYZ</a>)</li>
<li>Ault Disruptive Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADRT#NYSE">ADRT</a>)</li>
<li>Nouveau Monde Graphite Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMG#NYSE">NMG</a>)</li>
<li>Bowhead Specialty Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOW#NYSE">BOW</a>)</li>
<li>Banco Santander-Chile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSAC#NYSE">BSAC</a>)</li>
<li>Logistic Properties of the Americas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>)</li>
<li>Xperi Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>)</li>
<li>ICL Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>)</li>
<li>Telefonica, S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEF#NYSE">TEF</a>)</li>
<li>Trinity Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRN#NYSE">TRN</a>)</li>
</ul>
The technical fallout also impacted trading on the following NYSE-Arca listed exchange traded funds:
<ul>
<li>Direxion Daily Aerospace &amp; Defense Bull 3X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFEN#NYSE">DFEN</a>)</li>
<li>MAX S&amp;P 500 4x Leveraged ETN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPRO#NYSE">UPRO</a>)</li>
<li>JPMorgan Core Plus Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCPB#NYSE">JCPB</a>)</li>
<li>Global X MSCI Argentina ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARGT#NYSE">ARGT</a>)</li>
<li>Nationwide Nasdaq-100 Risk-Managed Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUSI#NYSE">NUSI</a>)</li>
<li>SPDR S&amp;P Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XSD#NYSE">XSD</a>)</li>
</ul>
Read now: <a href="https://www.benzinga.com/news/24/06/39136240/koss-corp-tupperware-blackberry-shares-are-moving-monday-whats-going-on">Koss Corp, Tupperware, BlackBerry Shares Are Moving Monday: What&#8217;s Going On?</a>
Photo via Shutterstock.

Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues (UPDATED)

ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 60.87 percent decrease over earnings of $0.23 per share from the same period last year. The company reported quarterly sales of $1.735 billion which missed the analyst consensus estimate of $1.752 billion by 0.95 percent. This is a 18.01 percent decrease over sales of $2.116 billion the same period last year.

ICL Group Q1 2024 GAAP EPS $0.09, Inline, Sales $1.735B Miss $1.752B Estimate

Barclays analyst Benjamin Theurer maintains ICL Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) with a Underweight and raises the price target from $4 to $4.5.

Barclays Maintains Underweight on ICL Group, Raises Price Target to $4.5

ICL&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICL#NYSE">ICL</a>) (TASE: ICL), a leading global specialty minerals company, today announced it has acquired Nitro 1000, a manufacturer, developer and provider of biologicals in Brazil for approximately&nbsp;$30 million. This acquisition marks another meaningful step into the biologicals market, while expanding ICL&#39;s product offerings and positioning the company for further expansions into new and adjacent end-markets.
Nitro 1000 will immediately join the ICL product portfolio, and the company will begin selling to its existing customer base in Brazil. Nitro 1000&#39;s products are mainly aimed at soybean, corn and sugar cane crops, and their application replaces or optimizes the use of fertilizers. This not only helps farmers increase profitability, it also offers a more sustainable solution.

ICL Group Snaps Nitro 1000, a Manufacturer, Developer and Provider of Biologicals in Brazil for $30M

ICL Group declares $0.0527 dividend

Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER – Tesla&nbsp;(TSLA) up 6% after Barron's wrote Elon Musk c...

Morning Movers: Cigna climbs after confirming not pursuing Humana deal

ICL Group Ltd (ICL) Q3 2024 Earnings Call Transcript

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.&nbsp; 1. STOCK NEWS: Cigna (CI) said it is not pursui...

Cigna drops pursuit of Humana: Morning Buzz

Icl Group Ltd. ( ($ICL) ) has released its Q3 earnings. Here is a breakdown of the information Icl Group Ltd. presented to its investors. ICL Group...

ICL Group Ltd. Reports Strong Q3 2024 Performance

Barclays analyst Benjamin Theurer maintained a Sell rating on Icl (ICL – Research Report) today and set a price target of $4.00. The company's shar...

Icl (ICL) Receives a Sell from Barclays

Icl (ICL) has released an update. ICL Group Ltd., a global leader in specialty minerals, reported a solid financial performance for Q3 2024, with s...

ICL Group Reports Strong Q3 2024 Financial Results

Icl (ICL) has released an update. ICL Group Ltd. has announced a cash dividend of $0.05270 per share, totaling approximately $68 million, to be dis...

ICL Group Declares $68 Million Dividend Payout

Icl (ICL) has released an update. ICL Group Ltd. reported a strong third quarter in 2024, achieving a sales figure of $1.753 billion and an 11% yea...

ICL Group Reports Strong Q3 Performance with Growth

The agriculture industry is experiencing considerable growth, driven by growing global food demand, increasing population, and adoption of advanced technologies. Hence, it could be wise to consider fundamentally solid agribusiness stocks Yara International (YARIY), Dole (DOLE), and ICL Group (ICL) as investments. Keep reading... Demand for agriculture remains constant, given the necessity of food for global sustenance and survival. Also, in recent periods, the market demand is further surging with evolving consumer behaviors and changing market trends, fueling the agricultural industry's demand. This is highly benefiting agribusinesses and promoting their activities. Currently, the market is undergoing transformative changes owing to increasing food demand, and agricultural trends.
Given this backdrop, it could be wise to consider fundamentally strong agriculture stocks Yara International ASA (<a href="https://stocknews.com/stock/YARIY/">YARIY</a>), Dole plc (<a href="https://stocknews.com/stock/DOLE/">DOLE</a>), and ICL Group Ltd (<a href="https://stocknews.com/stock/ICL/">ICL</a>) as global food demand surges.
In 2024, United States led the market for global exports during the first half. In the second quarter, world <a href="https://www.exportplanning.com/en/magazine/article/2024/08/19/food-beverage-united-states-by-far-the-leading-market-for-global-exports-in-the-first-half-of-2024/">exports of Packaged Food and Beverages to USA</a> recorded a year-over-year increase of nearly €1.7 billion ($1.83 billion) indicating strong food demand. Revenue in the US food market is expected to grow at a <a href="https://www.statista.com/outlook/cmo/food/united-states#:~:text=The%20Food%20market%20is%20expected,to%20488.00kg%20in%202024.">CAGR of 4.1%</a> during the forecast period (2024-2029).
These food demand trends are fueling demand for agricultural products, subsequently resulting in increased crop cultivation and production activities. Also, rising worldwide population, globalization of trade and favorable government policies have vastly contributed to the market growth.
With this, the agriculture market is expected to grow to $19.29 trillion by 2028, exhibiting growth at a <a href="https://www.thebusinessresearchcompany.com/report/agriculture-global-market-report">CAGR of 7.7%</a> driven by trends like vertical farming, sustainable agriculture practices, water management solutions, adoption of new technologies, and organic farming.
Considering the encouraging economic trends, let's delve into the fundamentals of the top three <a href="https://stocknews.com/category/agriculture/">Agriculture</a> stocks, beginning with the third choice.
Stock #3: Yara International ASA (<a href="https://stocknews.com/stock/YARIY/">YARIY</a>)
Headquartered in Oslo, Norway, YARIY offers crop nutrition and industrial solutions internationally. It offers ammonium- and urea-based fertilizers, coatings, biostimulants, organic-based fertilizers, as well as nitrate, calcium nitrate, micronutrient, and fertigation fertilizers.
On October 2, YARIY unveiled its new ammonia import terminal in Brunsbüttel, Germany, having capabilities of importing up to three million tons of low-emission ammonia annually. The facility is aimed at supporting the German hydrogen economy and contribute to the country's energy transition toward a low-carbon future.
During the third quarter that ended September 30, 2024, YARIY reported revenue and other income of $3.65 billion. Its operating income was $309 million, up 147.2% year-over-year. In addition, the company's adjusted <a href="https://www.investopedia.com/terms/e/ebitda.asp">EBITDA</a> grew 52.1% from the year-ago value to $604 million.
Furthermore, the company's net income and EPS came in at $286 million and $1.12 for the quarter, respectively.
Analysts expect YARIY's revenue for the fourth quarter (ending December 2024) to grow 1.2% year-over-year to $3.65 billion. For the fiscal year 2025, the company's revenue is expected to increase 4.5% year-over-year to $14.68 billion.
Shares of YARIY have surged 5.8% over the past three months and 1% over the past six months to close the last trading session at $14.64.
YARIY's solid fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
YARIY has a B grade for Value and Stability. It is ranked #7 out of 24 stocks in the <a href="https://stocknews.com/category/agriculture/">Agriculture</a> industry.
In addition to the POWR Ratings we've stated above, we also have YARIY ratings for Momentum, Quality, Growth, and Sentiment. Get all YARIY ratings <a href="https://stocknews.com/stock/YARIY/">here</a>.
Stock #2: Dole plc (<a href="https://stocknews.com/stock/DOLE/">DOLE</a>)
Based in Dublin, Ireland, DOLE engages in sourcing, processing, marketing, and distribution of fresh fruit and vegetables worldwide. The company operates in three segments: Fresh Fruit; Diversified Fresh Produce - EMEA; and Diversified Fresh Produce - Americas and ROW.
On August 13, DOLE's Board of Directors declared a cash dividend for the second quarter of 2024 of $0.08 per share, paid on October 3, 2024 to shareholders of record on September 11, 2024. DOLE pays an annual dividend of $0.32, which translates to a yield of 1.93% at the current share price. Its four-year average dividend yield is 2.14%.
In terms of forward non-GAAP P/E, DOLE is trading at 13.33x, 24% lower than the industry average of 17.53x. Similarly, the stock's forward Price/Sales multiple of 0.19 is 85.1% lower than the 1.28 industry average. Also, its forward EV/EBITDA of 7.28x is considerably lower than the industry average of 11.02x.
DOLE reported revenue of $2.12 billion during the second quarter that ended June 30, 2024. Its adjusted gross profit rose 2% year-over-year to $200.74 million. The company's adjusted operating income of $85.94 million indicates growth of 1.5% from the year-ago value.
Furthermore, net income attributable to DOLE came in at $80.12 million and $0.84 per share, up 89.5% and 90.9% from the prior year's quarter, respectively. Its adjusted EBITDA rose 2.2% from the year-ago value to $125.42 million.
Analysts expect DOLE's revenue and EPS for the fiscal year (ending December 2024) to increase marginally year-over-year to $8.27 billion and $1.24, respectively. Also, the company topped the consensus EPS estimates in all four trailing quarters, which is impressive.
DOLE's stock has gained 33.3% over the past six months and 43.8% over the past year to close the last trading session at $16.58.
DOLE's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
The stock has a B grade for Value, Stability, and Sentiment. DOLE is ranked #2 among the 24 stocks in the Agriculture industry.
<a href="https://stocknews.com/stock/DOLE/">Click here</a> to access DOLE's ratings for Quality, Growth, and Momentum.
Stock #1: ICL Group Ltd (<a href="https://stocknews.com/stock/ICL/">ICL</a>)
Headquartered in Tel Aviv, Israel, ICL operates as a specialty minerals and chemicals company globally. It operates in Industrial Products; Potash; Phosphate Solutions; and Growing Solutions segments. It produces bromine out of a solution that is a by-product of the potash production process, and bromine-based compounds.
On September 25, ICL announced a partnership with Orbia to supply a phosphorus compound for making LiPF6 battery materials. The partnership will strengthen the companies' position in North America's battery supply chain.
On September 24, ICL opened a new food specialty plant in China, which will create solutions for the meat, poultry, and seafood industries, boosting ICL's innovation and customization while expanding its presence in the Chinese market.
For the second quarter that ended June 30, 2024, ICL reported sales of $1.75 billion, up 1% from the prior quarter. Its adjusted operating income grew 4.7% quarter-on-quarter to $225 million. The company's adjusted EBITDA increased 4.1% from the previous quarter to $377 million.
Furthermore, adjusted net income attributable to shareholders and EPS came in at $126 million and $0.10, up 6.8% and 11.1% from the prior quarter, respectively.
Street expects ICL's revenue for the fiscal year (ending December 2025) to increase 6.3% year-over-year to $7.38 billion. Similarly, the company's EPS is expected to grow 26.5% year-over-year to $0.44 for the next year. Furthermore, ICL has surpassed the consensus EPS estimates in each of the trailing four quarters.
ICL's stock has gained 3.1% over the past month to close the last trading session at $4.23.
ICL's POWR Ratings reflect its robust outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
The stock has an A grade for Value and a B for Quality and Sentiment. Within the same industry, ICL has topped among the 24 stocks.
<a href="https://stocknews.com/stock/ICL/">Click here</a> to access additional ratings of ICL for Stability, Growth, and Momentum.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
YARIY shares were unchanged in after-hours trading Friday. Year-to-date, YARIY has declined -17.09%, versus a 27.04% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/yariy-icl-dole-3-agribusiness-stocks-to-consider-as-global-food-demand-grows/>3 Agribusiness Stocks to Consider as Global Food Demand Grows</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Agribusiness Stocks to Consider as Global Food Demand Grows

ABBV

AMZN

BLMN

CSCO

DOLE

GEHC

HIVE

MARA

MDRX

NRDY

NVDA

ORCL

PINS

RDNT

SPRB

TSLA

YARIY

Press Releases

ICL Continues Expanding Its Specialty Plant Nutrition Footprint in North America

ICL Reports Second Quarter 2024 Results

Small Cap

Israel Corp. Reports Results for Second Quarter of 2024

ICL to Participate in Fireside Chat at Jefferies 2024 Industrials Conference

ICL Continues Global Specialty Fertilizers Expansion With ~$170 Million Distribution Agreement in China

ICL Makes Significant Expansion in China, with Opening of New Food Specialty Plant

ICL Expands Further into North American Energy Storage Supply Chain by Partnering with Orbia Fluor & Energy Materials

Comments

ICL Group

매도 수량

ICL Group (NYSE:ICL) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌